0001209191-21-014743.txt : 20210226
0001209191-21-014743.hdr.sgml : 20210226
20210226162032
ACCESSION NUMBER: 0001209191-21-014743
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210224
FILED AS OF DATE: 20210226
DATE AS OF CHANGE: 20210226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 21689155
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-24
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2021-02-24
4
F
0
2946
217.57
D
43719
D
Common Stock
2021-02-25
4
S
0
922
211.56
D
42797
D
Common Stock
2021-02-25
4
S
0
1460
213.30
D
41337
D
Common Stock
2021-02-25
4
S
0
668
214.19
D
40669
D
Common Stock
2021-02-25
4
S
0
336
215.56
D
40333
D
Common Stock
2021-02-25
4
S
0
200
216.62
D
40133
D
Common Stock
882
I
401(k)
Common Stock
7368
I
Held in trust
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $211.56 (range $211.06 to $211.87).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $213.30 (range $212.93 to $213.88).
Open market sales reported on this line occurred at a weighted average price of $214.19 (range $213.94 to $214.78).
Open market sales reported on this line occurred at a weighted average price of $215.56 (range $215.12 to $215.85).
/s/ Sabrina Yohai, Attorney-in-Fact
2021-02-26